Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125862131 | 12586213 | 1 | I | 20160203 | 20160725 | 20160725 | PER | US-JAZZ-2016-US-002087 | JAZZ | 0.00 | F | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125862131 | 12586213 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 125862131 | 12586213 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | 21196 | ORAL SOLUTION | |||||||||||
| 125862131 | 12586213 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | DECREASED FROM 600 MG TO 400 MG | 0 | TABLET | ||||||||||
| 125862131 | 12586213 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125862131 | 12586213 | 5 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 6 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125862131 | 12586213 | 7 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 8 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 9 | C | Gildess Fe | ETHINYL ESTRADIOLNORETHINDRONE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 10 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | UNK | U | 0 | NASAL SPRAY | |||||||||
| 125862131 | 12586213 | 11 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | U | 0 | ||||||||||
| 125862131 | 12586213 | 12 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 13 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 14 | C | BUSPAR | BUSPIRONE HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 15 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 16 | C | LO LOESTRIN FE | ETHINYL ESTRADIOLNORETHINDRONE ACETATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 17 | C | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125862131 | 12586213 | 18 | C | NEURONTIN | GABAPENTIN | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125862131 | 12586213 | 19 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125862131 | 12586213 | 1 | Narcolepsy |
| 125862131 | 12586213 | 2 | Cataplexy |
| 125862131 | 12586213 | 3 | Product used for unknown indication |
| 125862131 | 12586213 | 4 | Product used for unknown indication |
| 125862131 | 12586213 | 5 | Product used for unknown indication |
| 125862131 | 12586213 | 6 | Product used for unknown indication |
| 125862131 | 12586213 | 7 | Product used for unknown indication |
| 125862131 | 12586213 | 8 | Product used for unknown indication |
| 125862131 | 12586213 | 9 | Product used for unknown indication |
| 125862131 | 12586213 | 10 | Product used for unknown indication |
| 125862131 | 12586213 | 11 | Product used for unknown indication |
| 125862131 | 12586213 | 12 | Product used for unknown indication |
| 125862131 | 12586213 | 13 | Product used for unknown indication |
| 125862131 | 12586213 | 14 | Product used for unknown indication |
| 125862131 | 12586213 | 15 | Product used for unknown indication |
| 125862131 | 12586213 | 16 | Product used for unknown indication |
| 125862131 | 12586213 | 17 | Product used for unknown indication |
| 125862131 | 12586213 | 18 | Product used for unknown indication |
| 125862131 | 12586213 | 19 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125862131 | 12586213 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125862131 | 12586213 | 1 | 200912 | 0 | ||
| 125862131 | 12586213 | 3 | 20150901 | 20151008 | 0 | |
| 125862131 | 12586213 | 4 | 20160115 | 0 | ||
| 125862131 | 12586213 | 5 | 20151120 | 0 | ||
| 125862131 | 12586213 | 6 | 20151117 | 0 | ||
| 125862131 | 12586213 | 7 | 20151111 | 20160113 | 0 | |
| 125862131 | 12586213 | 8 | 20151111 | 20160113 | 0 | |
| 125862131 | 12586213 | 9 | 20151008 | 0 | ||
| 125862131 | 12586213 | 10 | 20151008 | 0 | ||
| 125862131 | 12586213 | 11 | 20151008 | 0 | ||
| 125862131 | 12586213 | 12 | 20151008 | 0 | ||
| 125862131 | 12586213 | 13 | 20151008 | 0 | ||
| 125862131 | 12586213 | 14 | 20010101 | 20151019 | 0 | |
| 125862131 | 12586213 | 15 | 20010101 | 20150115 | 0 | |
| 125862131 | 12586213 | 16 | 20010101 | 20151019 | 0 | |
| 125862131 | 12586213 | 17 | 20010101 | 20151101 | 0 | |
| 125862131 | 12586213 | 19 | 20151201 | 0 |